Stocks Listing
BHC

Bausch Health Companies Inc.

Share
BHC
$6.92 0.29%Last Updated Sep 30 2022 07:56 PM
1D Low / 1D High
Low:$6.79
High:$7.25
1D
0.29%
5D
4.81 %
30D
10.54 %
BulletPurple
Market Cap
$2,520,704,256
0.5 %
2.5 B
BulletBlue
Volume 1D
4,741,166
-
4.7 M
BulletOrange
Circulating Supply
364,527,007 BHC
364.5 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Opened
NYQ
New York Stock Exchange
USA
Closes in
5 hours, 49 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0